INmune Bio Inc

-0.46 (-2.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)324.74M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.97 Million
Adjusted EPS-$0.38
See more estimates
10-Day MA$18.49
50-Day MA$19.29
200-Day MA$17.03
See more pivots

INmune Bio Inc Stock, NASDAQ:INMB

1200 Prospect Street, Suite 525, La Jolla, California 92037
United States of America
Phone: +1.858.964.3720
Number of Employees: 5


INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimerâ??s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.